Log In
BCIQ
Print this Print this
 

DLX2201

  Manage Alerts
Collapse Summary General Information
Company Cell Medica Ltd.
DescriptionPentrabody against IL-12/IL-23
Molecular Target Interleukin-12 (IL-12) ; Interleukin-23 (IL-23)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/12/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today